Enteroviral Pathogenesis of Type 1 Diabetes

被引:0
|
作者
Hober, Didier [1 ]
Sane, Famara [1 ]
机构
[1] Univ Lille 2, CHRU Lille, EA3610, Lab Virol,Fac Med,Inst Hippocrate, F-59120 Loos Lez Lille, France
关键词
BLOOD MONONUCLEAR-CELLS; COXSACKIEVIRUS B4; RISK-FACTOR; BETA-CELLS; DEPENDENT ENHANCEMENT; PANCREATIC-ISLETS; INTERFERON-ALPHA; PROTEIN VP4; ANTIBODIES; INFECTION;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Type 1 diabetes (T1D) is an autoimmune disease characterized by the disturbance of pancreatic insulin-producing cells, which results in hyperglycemia. The disease is associated with severe complications that impair the quality of life of individuals. The cause of T1D is unknown. Development of the disease is the result of interactions between immunological, genetic, and environmental factors. Viruses are thought to play an important role in the initiation or acceleration of the disease. This is an important issue since it opens the possibility to develop new preventive and therapeutic strategies to fight the disease. The role of enteroviruses in the development of T1D, in particular type B coxsackieviruses, is supported by epidemiological observations. It has been demonstrated that enterovirus infections were significantly more common in recently diagnosed diabetic patients, compared with control subjects. Enteroviral RNA and/or proteins can be detected in blood samples and intestine biopsies of patients with T1D. The hypothesis of a relationship between enteroviruses and the disease has been strengthened by the presence of enteroviral components or infectious particles in the pancreas of patients with T1D. In this review, arguments in favor of a relationship between enterovirus infections and T1D and the mechanisms of the enteroviral pathogenesis of the disease are presented. [Discovery Medicine 10(51):151-160, August 2010]
引用
收藏
页码:151 / 160
页数:10
相关论文
共 50 条
  • [1] Enteroviral pathogenesis of type 1 diabetes: queries and answers
    Hober, Didier
    Alidjinou, Enagnon K.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2013, 26 (03) : 263 - 269
  • [2] Enteroviral Pathogenesis of Type 1 Diabetes: The Role of Natural Killer Cells
    Nekoua, Magloire Pandoua
    Dechaumes, Arthur
    Sane, Famara
    Alidjinou, Enagnon Kazali
    Moutairou, Kabirou
    Yessoufou, Akadiri
    Hober, Didier
    MICROORGANISMS, 2020, 8 (07) : 1 - 17
  • [3] Enteroviral infections in the pathogenesis of type 1 diabetes: new insights for therapeutic intervention
    Richardson, Sarah J.
    Morgan, Noel G.
    CURRENT OPINION IN PHARMACOLOGY, 2018, 43 : 11 - 19
  • [4] Enteroviral Infections as a Trigger for Type 1 Diabetes
    Teresa Rodriguez-Calvo
    Current Diabetes Reports, 2018, 18
  • [5] Enteroviral Infections as a Trigger for Type 1 Diabetes
    Rodriguez-Calvo, Teresa
    CURRENT DIABETES REPORTS, 2018, 18 (11)
  • [6] Fighting Enteroviral Infections to Prevent Type 1 Diabetes
    Nekoua, Magloire Pandoua
    Mercier, Ambroise
    Alhazmi, Abdulaziz
    Sane, Famara
    Alidjinou, Enagnon Kazali
    Hober, Didier
    MICROORGANISMS, 2022, 10 (04)
  • [7] Enteroviral vp1 expression in human Type 1 diabetes
    Richardson, S. J.
    Willcox, A.
    Bonew, A. J.
    Foulis, A. K.
    Morgan, N. G.
    DIABETIC MEDICINE, 2008, 25
  • [8] Enteroviral mRNA detection in the pancreas of patients with type 1 diabetes
    Geravandi, S.
    Maedler, K.
    DIABETOLOGIA, 2019, 62 : S7 - S7
  • [9] Developing a vaccine for Type 1 diabetes through targeting enteroviral infections
    Hyoty, Heikki
    Knip, Mikael
    EXPERT REVIEW OF VACCINES, 2014, 13 (08) : 989 - 999
  • [10] Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes
    Jessica L. Dunne
    Sarah J. Richardson
    Mark A. Atkinson
    Maria E. Craig
    Knut Dahl-Jørgensen
    Malin Flodström-Tullberg
    Heikki Hyöty
    Richard A. Insel
    Åke Lernmark
    Richard E. Lloyd
    Noel G. Morgan
    Alberto Pugliese
    Diabetologia, 2019, 62 : 744 - 753